Hyperbranched polyamidoamines containing beta-cyclodextrin for controlled release of chlorambucil

Area of Science:

• Polymer Chemistry
• Drug Delivery Systems
• Materials Science

Background:

• Controlled drug release is crucial for effective cancer therapy.
• Hyperbranched polymers of N-(2-hydroxypropyl) methacrylamide (HPMA) are investigated for drug delivery.
• Beta-cyclodextrin (beta-CD) can form inclusion complexes, influencing drug release.

Purpose of the Study:

• To synthesize and characterize HPMA-beta-CD copolymers.
• To investigate the in vitro release of the anti-cancer drug CLB from these polymers.
• To evaluate the effect of beta-CD content on drug loading and release kinetics.

Main Methods:

• Synthesis of HPMA-beta-CDs and pure HPMA via Michael addition polymerization.
• Loading of CLB (anti-cancer drug) into polymers using a solution method.
• In vitro drug release studies.
• Differential Scanning Calorimetry (DSC) to analyze polymer-drug interactions and glass transition temperatures (Tg).

Main Results:

• HPMA-beta-CDs and pure HPMA were successfully synthesized.
• DSC indicated molecular-level interactions between CLB and the polymers.
• CLB loading increased the glass transition temperature (Tg) of the polymers, with the increase dependent on beta-CD content.
• Controlled-release experiments demonstrated that beta-CD inclusion slowed CLB release and modulated the release ratio.

Conclusions:

• HPMA-beta-CD copolymers offer a promising platform for controlled drug delivery.
• The incorporation of beta-CD effectively modulates the release profile of the anti-cancer drug CLB.
• These findings suggest potential for developing advanced drug delivery systems with tunable release characteristics.